The association between antiphospholipid antibodies and pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: A critical review of the literature

Lupus

Volumn 24, Issue 9, 2015, Pages 980-984

  Chighizola, C B ^a   Andreoli, L ^b   De Jesus, G Ramires ^c   Banzato, A ^d   Pons Estel, G J ^e   Erkan, D ^f,g  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

^c STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d UNIVERSITY OF PADOVA   (Italy)

^e HOSPITAL CLÍNIC   (Spain)

^f HOSPITAL FOR SPECIAL SURGERY   (United States)

^g WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Antiphospholipid antibodies; antiphospholipid syndrome; epidemiology

Indexed keywords

PHOSPHOLIPID ANTIBODY; LUPUS ANTICOAGULANT;

CEREBROVASCULAR ACCIDENT; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART INFARCTION; HELLP SYNDROME; HUMAN; MORBIDITY; OUTCOME ASSESSMENT; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; ANTIPHOSPHOLIPID SYNDROME; IMMUNOLOGY; INTRAUTERINE GROWTH RETARDATION; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; SPONTANEOUS ABORTION; VEIN THROMBOSIS;

ABORTION, SPONTANEOUS; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; FEMALE; FETAL GROWTH RETARDATION; HUMANS; LUPUS COAGULATION INHIBITOR; MORBIDITY; MYOCARDIAL INFARCTION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; STROKE; VENOUS THROMBOSIS;

EID: 84937823546     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203315572714     Document Type: Review

References (12)

1. Miyakis S, Lockshin MD, Atsumi T,. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
2. Wilson WA, Gharavi AE, Koike T,. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop. Arthritis Rheum 1999; 42: 1309-1311.
3. Andreoli L, Chighizola CB, Banzato A, Pons-Estel GJ, de Jesus GR, Erkan D,. The estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis. Arthritis Care Res (Hoboken) 2013; 65: 1869-1873.
4. Galli M, Luciani D, Bertolini G, Barbui T,. Lupus anticoagulant are stronger risk factors for thrombotic than anticardiolipin antibodies in the antiphospholipid syndrome: A systematic review of the literature. Blood 2003; 101: 1827-1832.
5. Opatrny L, David M, Kahn SR, Shrier I, Rey E,. Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: A metaanalysis. J Rheumatol 2006; 33: 2214-2221.
6. Abou-Nassar K, Carrier M, Ramsay T, Rodger MA,. The association between antiphospholipid antibodies and placenta mediated complications: A systematic review and meta-analysis. Thromb Res 2011; 128: 77-85.
7. do Prado AD, Piovesan DM, Staub HL, Horta BL,. Association of anticardiolipin antibodies with preeclampsia. Obstet Gynecol 2010; 116: 1433-1443.
8. Galli M, Luciani D, Bertolini G, Barbui T,. Anti-β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood 2002; 102: 2717-2723.
9. Meroni PL, Chighizola CB, Rovelli F, Gerosa M,. Antiphospholipid syndrome in 2014: More clinical manifestations, novel pathogenic players and emerging biomarkers. Arthritis Res Ther 2014; 16: 209-209.
10. Silver RM, Parker CB, Reddy UM,. Antiphospholipid antibodies in stillbirth. Obstet Gynecol 2013; 122: 641-657.
11. Clark C, Laskin C,. Unrealistic estimation of population prevalence aPL-related pregnancy loss. Arthritis Care Res (Hoboken) 2014; 66: 966-966.
12. Chighizola CB, Andreoli L, Erkan D,. Reply to letter to editor. Arthritis Care Res (Hoboken) 2014; 66: 966-967.